Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NCT07166094 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

660

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
Recurrent or Progressive Endometrial Cancer

Interventions

DRUG: Rina-S
DRUG: IC

Sponsor

Genmab